ARTICLE | Distillery Therapeutics
Cancer
April 10, 2018 10:54 PM UTC
In vitro and mouse studies identified an α-galactosylceramide (α-GalCer)-based antigen that could enhance the antitumor immunity of invariant natural killer T (NKT) cells to treat metastatic melanoma....